(NAPSI)—Chronic obstructive pulmonary disease (COPD) affects approximately 16 million Americans and can make even simple ...
What’s it like living with one of NZ’s most lethal conditions: Chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease (COPD), which encompasses emphysema, chronic bronchitis and long-standing asthma, affects 14% of Kiwis aged over 40 years old and is the fourth-leading cause of ...
A growing evidence base shows that chronic obstructive pulmonary disease (COPD) is affected by climate and environmental exposures, not only through extreme temperature exposure and air pollution but ...
Certain neighborhood characteristics, including higher poverty, more uninsured residents, and lower educational attainment, may lead to an increase in COPD-related emergency department visits and ...
WHITTIER, Calif., Nov. 19, 2025 /PRNewswire/ -- PIH Health Whittier Hospital is now offering the Zephyr® Endobronchial Valve procedure, a breakthrough minimally invasive treatment option for patients ...
WAYNETOWN, Ind. — Tony Manion doesn't miss a workout. Seriously. Three hours a day, every day. "You just make a choice to do it," Manion said, between reps from his home gym in rural Montgomery County ...
WILLIAMSPORT, Pa. — November is Chronic Obstructive Pulmonary Disease or COPD Awareness Month. The American Lung Association says COPD affects more than 11 million adults and accounts for hundreds of ...
Biological therapy was associated with significant changes in lung structure and, by extension, improved lung function in individuals with chronic obstructive pulmonary disease (COPD) and T2 ...
Using a care pathway focused on chronic obstructive pulmonary disease (COPD) can lead to shorter hospital stays, increased referrals to pulmonary rehabilitation, and improved standardization of care, ...
Please provide your email address to receive an email when new articles are posted on . This analysis examined three phenotypes of pulmonary hypertension (PH) associated with COPD. Patients with ...
The study will evaluate a novel device designed to open airways and release trapped air in patients with severe emphysema and hyperinflation. Dr. Gerard Criner is a Principal Investigator ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results